Avadel Pharmaceuticals plc(AVDL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

AVDL Avadel Pharmaceuticals plc

Post-Market Trading 11-15 16:55:21 EST

10.91

-0.68

-5.87%

盘后10.91

+0.000.00%

16:20 EST

High11.61	Low10.62	Vol2.08M
Open11.57	D1 Closing11.59	Amplitude8.50%
Mkt Cap1.05B	Tradable Cap908.86M	Total Shares96.36M
T/O22.76M	T/O Rate2.49%	Tradable Shares83.31M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"AVDL","market":"US","secType":"STK","nameCN":"Avadel Pharmaceuticals plc","latestPrice":10.91,"timestamp":1731704400000,"preClose":11.59,"halted":0,"volume":2076277,"hourTrading":{"tag":"盘后","latestPrice":10.91,"preClose":10.91,"latestTime":"16:20 EST","volume":22437,"amount":244755.517779,"timestamp":1731705600464},"delay":0,"floatShares":83305167,"shares":96361528,"eps":-0.776072,"marketStatus":"Post-Market Trading","change":-0.68,"latestTime":"11-15 16:55:21 EST","open":11.57,"high":11.605,"low":10.62,"amount":22755852.080624,"amplitude":0.084987,"askPrice":10.99,"askSize":1100,"bidPrice":10.6,"bidSize":50,"shortable":3,"etf":0,"ttmEps":-0.776072,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1731718800000},"marketStatusCode":4,"adr":1,"adrRate":1,"exchange":"NASDAQ","adjPreClose":11.59,"preHourTrading":{"tag":"盘前","latestPrice":11.2,"preClose":11.59,"latestTime":"08:02 EST","volume":5,"amount":56,"timestamp":1731675775200},"postHourTrading":{"tag":"盘后","latestPrice":10.91,"preClose":10.91,"latestTime":"16:20 EST","volume":22437,"amount":244755.517779,"timestamp":1731705600464},"volumeRatio":0.716024,"impliedVol":0.6931,"impliedVolPercentile":0.3929},"requestUrl":"/m/hq/s/AVDL","defaultTab":"news","newsList":[{"id":"2483482178","title":"Avadel Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2483482178","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483482178?lang=en_us&edition=fundamental","pubTime":"2024-11-14 18:16","pubTimestamp":1731579392,"startTime":"0","endTime":"0","summary":"NasdaqGM:AVDL Earnings and Revenue Growth November 14th 2024. All figures shown in the chart above are for the trailing 12 month  period. Revenue exceeded analyst estimates by 2.9%. Earnings per share  also surpassed analyst estimates by 50%.Looking ahead, revenue is forecast to grow 29% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Pharmaceuticals industry in the US.The company's shares are down 21% from a week ago.Before we wrap up, we've discovered 1 warning sign for Avadel Pharmaceuticals that you should be aware of.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/avadel-pharmaceuticals-third-quarter-2024-101632545.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AVDL"],"gpt_icon":0},{"id":"2483029014","title":"Avadel Pharmaceuticals PLC (AVDL) Q3 2024 Earnings Call Highlights: Strong Patient Growth and ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2483029014","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483029014?lang=en_us&edition=fundamental","pubTime":"2024-11-13 15:09","pubTimestamp":1731481796,"startTime":"0","endTime":"0","summary":"Net Revenue: $50 million in the third quarter.Operating Expenses: $44.2 million GAAP operating expenses, with $37.8 million in cash operating expenses.Cash and Equivalents: $66 million as of September 30.Active Patients: 2,300 patients on therapy as of September 30.New Patient Starts: 700 patients initiated therapy in Q3.Gross Margin: Impacted by approximately 3.5% due to a onetime adjustment related to potential royalty.GuruFocus has detected 5 Warning Signs with AVDL.For the complete transcript of the earnings call, please refer to the full earnings call transcript.Avadel Pharmaceuticals PLC  reported consistent patient growth for LUMRYZ, with 2,300 active patients and 700 new initiations in Q3, resulting in $50 million in net revenue.The company received FDA approval and orphan drug exclusivity for LUMRYZ in pediatric patients, expanding its treatment reach.Avadel Pharmaceuticals PLC  secured a favorable court ruling affirming FDA's approval and clinical superiority decision for LUM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/avadel-pharmaceuticals-plc-avdl-q3-070956147.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AVDL"],"gpt_icon":0},{"id":"2483048201","title":"Avadel Pharmaceuticals Plc :  Piper Sandler Raises Target Price to $24 From $23","url":"https://stock-news.laohu8.com/highlight/detail?id=2483048201","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483048201?lang=en_us&edition=fundamental","pubTime":"2024-11-13 12:56","pubTimestamp":1731473810,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nFWN3MK003:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","AVDL"],"gpt_icon":0},{"id":"2482822950","title":"Avadel Pharmaceuticals PLC reports results for the quarter ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2482822950","media":"reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482822950?lang=en_us&edition=fundamental","pubTime":"2024-11-12 23:39","pubTimestamp":1731425991,"startTime":"0","endTime":"0","summary":"Avadel Pharmaceuticals PLC reports results for the quarter ended September 30 - Earnings SummaryAvadel Pharmaceuticals PLC AVDL.OQ reported a quarterly adjusted loss of 3 cents per share for the quart","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241112:nL8N3MJ2BQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVDL"],"gpt_icon":0},{"id":"2482709660","title":"Avadel Pharmaceuticals Price Target Maintained With a $22.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2482709660","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482709660?lang=en_us&edition=fundamental","pubTime":"2024-11-12 20:56","pubTimestamp":1731416160,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AVDL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 12, 2024 07:56 ET (12:56 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVDL"],"gpt_icon":0},{"id":"2482070555","title":"Avadel Pharmaceuticals' Q3 Loss Narrows, Revenue Rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2482070555","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482070555?lang=en_us&edition=fundamental","pubTime":"2024-11-12 20:24","pubTimestamp":1731414243,"startTime":"0","endTime":"0","summary":"Avadel Pharmaceuticals  reported a Q3 loss Tuesday of $0.03 per diluted share, narrower than a loss of $0.41 a year earlier.Four analysts polled by Capital IQ expected a loss of $0.06.Revenue for the quarter ended Sept. 30 was $50 million compared with $7 million a year earlier.Analysts surveyed by Capital IQ expected $48.6 million.Price: 15.00, Change: -0.05, Percent Change: -0.33","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AVDL"],"gpt_icon":0},{"id":"2482092177","title":"Avadel: Q3 Earnings Snapshot","url":"https://stock-news.laohu8.com/highlight/detail?id=2482092177","media":"Associated Press Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482092177?lang=en_us&edition=fundamental","pubTime":"2024-11-12 20:21","pubTimestamp":1731414107,"startTime":"0","endTime":"0","summary":"DUBLIN  — DUBLIN  — Avadel Pharmaceuticals PLC  on Tuesday reported a loss of $2.6 million in its third quarter.The Dublin-based company said it had a loss of 3 cents per share.The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 6 cents per share.The specialty pharmaceutical company posted revenue of $50 million in the period, also exceeding Street forecasts. Five analysts surveyed by Zacks expected $49.1 million.Avadel shares have increased 15% since the beginning of the year. The stock has increased 47% in the last 12 months.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/avadel-q3-earnings-snapshot-122147705.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AVDL"],"gpt_icon":0},{"id":"2482170894","title":"Avadel Pharmaceuticals Q3 2024 GAAP EPS $(0.03) Beats $(0.06) Estimate, Sales $50.025M Beat $48.607M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2482170894","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482170894?lang=en_us&edition=fundamental","pubTime":"2024-11-12 20:03","pubTimestamp":1731413027,"startTime":"0","endTime":"0","summary":"Avadel Pharmaceuticals (NASDAQ:AVDL) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.06) by 50 percent. This is a 92.68 percent increase over losses of $(0.41) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41896630/avadel-pharmaceuticals-q3-2024-gaap-eps-0-03-beats-0-06-estimate-sales-50-025m-beat-48-607m-estimat","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Avadel Pharmaceuticals Q3 2024 GAAP EPS $(0.03) Beats $(0.06) Estimate, Sales $50.025M Beat $48.607M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVDL"],"gpt_icon":0},{"id":"2482506481","title":"Avadel Pharmaceuticals PLC  expected to post a loss of 6 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2482506481","media":"reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482506481?lang=en_us&edition=fundamental","pubTime":"2024-11-09 00:32","pubTimestamp":1731083530,"startTime":"0","endTime":"0","summary":"Avadel Pharmaceuticals PLC  expected to post a loss of6cents a share - Earnings Preview Avadel Pharmaceuticals PLC AVDL.OQ AVDL.O is expected to show a rise in quarterly revenue when it reports  resul","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL8N3MF2S1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVDL"],"gpt_icon":0},{"id":"2480070873","title":"Avadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter 2024 Financial Results on November 12","url":"https://stock-news.laohu8.com/highlight/detail?id=2480070873","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480070873?lang=en_us&edition=fundamental","pubTime":"2024-11-04 21:00","pubTimestamp":1730725201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241104:nTUA2SSMGR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","AVDL"],"gpt_icon":0},{"id":"2480005013","title":"Avadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter 2024 Financial Results on November 12","url":"https://stock-news.laohu8.com/highlight/detail?id=2480005013","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480005013?lang=en_us&edition=fundamental","pubTime":"2024-11-04 21:00","pubTimestamp":1730725200,"startTime":"0","endTime":"0","summary":"DUBLIN, Nov. 04, 2024  -- Avadel Pharmaceuticals plc , a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it will host a conference call and live webcast at 8:30 a.m. ET on Tuesday, November 12, 2024, to provide a corporate update and discuss the Company's financial results for the third quarter ended September 30, 2024.To access the conference call, investors are invited to dial  579-2543  and reference the conference ID AVADEL. A live audio webcast of the call be accessed by visiting the investor relations section of the Company’s website,www.avadel.com. A replay of the webcast will be archived on Avadel’s website for 90 days following the event.About Avadel Pharmaceuticals plcAvadel Pharmaceuticalsplc is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatmen","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/S85ZqfPWAwheMFjSr0hjHQ--~B/aD00NDt3PTE3NDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/62cb952a5304c223edbe85220b83106b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/S85ZqfPWAwheMFjSr0hjHQ--~B/aD00NDt3PTE3NDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/62cb952a5304c223edbe85220b83106b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/avadel-pharmaceuticals-corporate-report-third-130000611.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AVDL","BK4007"],"gpt_icon":0},{"id":"2480300077","title":"Loss-Making Avadel Pharmaceuticals plc (NASDAQ:AVDL) Expected To Breakeven In The Medium-Term","url":"https://stock-news.laohu8.com/highlight/detail?id=2480300077","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480300077?lang=en_us&edition=fundamental","pubTime":"2024-11-01 20:05","pubTimestamp":1730462719,"startTime":"0","endTime":"0","summary":"Avadel Pharmaceuticals plc  is possibly approaching a major achievement in its business, so we would like to shine some light on the company. Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. With the latest financial year loss of US$160m and a trailing-twelve-month loss of US$106m, the US$1.5b market-cap company alleviated its loss by moving closer towards its target of breakeven. As path to profitability is the topic on Avadel Pharmaceuticals' investors mind, we've decided to gauge market sentiment. Below we will provide a high-level summary of the industry analysts’ expectations for the company.Check out our latest analysis for Avadel Pharmaceuticals. NasdaqGM:AVDL Earnings Per Share Growth November 1st 2024","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/H9sVDVM9mi9ws1HvXhxW7w--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/H9sVDVM9mi9ws1HvXhxW7w--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/loss-making-avadel-pharmaceuticals-plc-120519126.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SQQQ","QID","NDAQ","PSQ","BK4588","IE00B64PRP62.GBP","LU2210150020.SGD","BK4007","IE00B3QW5Z07.USD","AVDL","BK4585","QLD","IE00BKPKM429.USD","MNQmain","NQmain","TQQQ","LU2210149790.SGD","BK4112","LU2095319765.USD","IE00BGHQF748.EUR",".IXIC"],"gpt_icon":1},{"id":"2479324032","title":"Avadel Pharma Shares Rise on Favorable Ruling for FDA in Lumryz Litigation","url":"https://stock-news.laohu8.com/highlight/detail?id=2479324032","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479324032?lang=en_us&edition=fundamental","pubTime":"2024-10-31 23:14","pubTimestamp":1730387640,"startTime":"0","endTime":"0","summary":"Shares in Avadel Pharmaceuticals rose more than 16% after a court ruled in favor of the Food and Drug Administration in a lawsuit brought by Jazz Pharmaceuticals regarding the approval of Lumryz, its once-at-bedtime oxybate for narcolepsy.Avadel's shares are trading at $15.02, up 16.3%. Year to date, the stock is up 5%.The Dublin-based biopharmaceutical company said with the ruling, in the U.S. District Court for the District of Columbia, the approval of Lumryz is upheld based on the FDA's determination that Lumryz is clinically superior to Jazz's twice-nightly oxybate products.Avadel said Lumryz is the first and only once-at-bedtime oxybate treatment for cataplexy or excessive daytime sleepiness in adults with narcolepsy.After the FDA's final approval and grant of orphan drug exclusivity to Lumryz in May 2023, Jazz filed a complaint claiming the approval wasn't in alignment with the Orphan Drug Act, Avadel said. Avadel then intervened to defend the FDA's actions and successfully argue","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","AVDL","LU0109394709.USD","LU0889565916.HKD","BK4533","BK4532","BK4007","JAZZ"],"gpt_icon":0},{"id":"2479349800","title":"Court ruling removes ‘last binary risk’ for Avadel, says H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2479349800","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479349800?lang=en_us&edition=fundamental","pubTime":"2024-10-31 22:50","pubTimestamp":1730386215,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Oren Livnat notes that the DC District Court ruled in Avadel’s (AVDL) favor in the Jazz (JAZZ) vs. FDA and Avadel case, whe...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/court-ruling-removes-last-binary-risk-for-avadel-says-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/court-ruling-removes-last-binary-risk-for-avadel-says-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","JAZZ","LU0889565916.HKD","LU0109394709.USD","LU0320765992.SGD","AVDL","BK4007","BK4533"],"gpt_icon":0},{"id":"2479086695","title":"Avadel Pharmaceuticals Price Target Maintained With a $22.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2479086695","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479086695?lang=en_us&edition=fundamental","pubTime":"2024-10-31 20:26","pubTimestamp":1730377560,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AVDL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 31, 2024 08:26 ET (12:26 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVDL"],"gpt_icon":0},{"id":"2479083027","title":"Oppenheimer Reaffirms Their Buy Rating on Avadel Pharmaceuticals (AVDL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2479083027","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479083027?lang=en_us&edition=fundamental","pubTime":"2024-10-31 20:09","pubTimestamp":1730376579,"startTime":"0","endTime":"0","summary":"Oppenheimer analyst Francois Brisebois maintained a Buy rating on Avadel Pharmaceuticals (AVDL – Research Report) today and set a price target of $...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/oppenheimer-reaffirms-their-buy-rating-on-avadel-pharmaceuticals-avdl-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/oppenheimer-reaffirms-their-buy-rating-on-avadel-pharmaceuticals-avdl-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVDL","OPY"],"gpt_icon":0},{"id":"2479083762","title":"Investors Await Key Inflation, Employment Data as US Futures Move Lower in Thursday's Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=2479083762","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479083762?lang=en_us&edition=fundamental","pubTime":"2024-10-31 20:09","pubTimestamp":1730376570,"startTime":"0","endTime":"0","summary":"US stock futures were tracking lower in Thursday's premarket session as investors await key inflation and employment data coming out later in the morning.The Dow Jones Industrial Average futures were ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4551","EQ","BK4082","ISBC","LU0320765992.SGD","BK4079","BK4139","TNON","AVDL","BK4533","MTNB","BK4107","LU0109394709.USD","BK4568","ROOT","BK4211","BK4505","BK4007","BK4532","MDJH","JAZZ","LU0889565916.HKD"],"gpt_icon":0},{"id":"2479108318","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2479108318","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479108318?lang=en_us&edition=fundamental","pubTime":"2024-10-31 19:56","pubTimestamp":1730375802,"startTime":"0","endTime":"0","summary":"Root  shares surged 82% in recent premarket activity Thursday, a day after it swung to Q3 profit and higher total revenue from a year earlier.Avadel Pharmaceuticals  stock jumped over 27% after saying the US District Court for the District of Columbia ruled in favor of the Food and Drug Administration against a lawsuit brought by Jazz Pharmaceuticals regarding the FDA's approval of Lumryz oxybate treatment.Carvana  stock rose 19%, a day after it reported higher Q3 revenue from a year earlier.Booking Holdings  shares were up 6% after it reported overnight higher Q3 adjusted earnings and total revenue from a year earlier.Price: 73.70, Change: +33.21, Percent Change: +82.02","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AVDL","BK4007","BK4548","LU0266013472.USD","SGXZ23171101.USD","LU0426412945.USD","LU1043141396.HKD","CVNA","LU1121112475.USD","LU0994945656.USD","LU0557290698.USD","LU2087625088.SGD","BK4107","BK4505","LU0942090050.USD","IE00BZ1G4Q59.USD","LU0868494708.USD","ROOT","LU1043141123.HKD","BK4588","LU0823411888.USD","LU0353189763.USD","BK4585","IE0004445239.USD","LU0353189680.USD","BK4534","LU1496350171.SGD","BKNG","LU0203347892.USD","LU1496350502.SGD","BK4503","LU0719512351.SGD","SG9999004303.SGD","LU0203345920.USD","BK4561","IE00BKVL7J92.USD","LU0426417589.USD","LU1571399168.USD","LU0868494617.USD","BK4214","LU0082616367.USD","BK4551","BK4142"],"gpt_icon":1},{"id":"2479045027","title":"BRIEF-Avadel Pharmaceuticals Announces Favorable Ruling In Administrative Procedure Act Litigation","url":"https://stock-news.laohu8.com/highlight/detail?id=2479045027","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479045027?lang=en_us&edition=fundamental","pubTime":"2024-10-31 19:09","pubTimestamp":1730372981,"startTime":"0","endTime":"0","summary":"Oct 31  - Avadel Pharmaceuticals PLC   :   * AVADEL PHARMACEUTICALS ANNOUNCES FAVORABLE RULING IN ADMINISTRATIVE PROCEDURE ACT LITIGATION   * AVADEL PHARMACEUTICALS PLC - LUMRYZ APPROVAL UPHELD BASED ON CLINICAL SUPERIORITYSource text:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AVDL"],"gpt_icon":0},{"id":"2479870162","title":"Avadel Pharmaceuticals Announces Favorable Ruling in Administrative Procedure Act Litigation","url":"https://stock-news.laohu8.com/highlight/detail?id=2479870162","media":"THOMSON REUTERS","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479870162?lang=en_us&edition=fundamental","pubTime":"2024-10-31 19:00","pubTimestamp":1730372402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241031:nTUA52GWQD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AVDL","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.avadel.com","stockEarnings":[{"period":"1week","weight":-0.2627},{"period":"1month","weight":-0.122},{"period":"3month","weight":-0.2729},{"period":"6month","weight":-0.2518},{"period":"1year","weight":0.0614},{"period":"ytd","weight":-0.1792}],"compareEarnings":[{"period":"1week","weight":-0.0038},{"period":"1month","weight":0.0234},{"period":"3month","weight":0.0704},{"period":"6month","weight":0.1207},{"period":"1year","weight":0.3195},{"period":"ytd","weight":0.2483}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is LUMRYZ, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness or cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.","yearOnYearQuotes":[{"month":1,"riseRate":0.607143,"avgChangeRate":0.060148},{"month":2,"riseRate":0.464286,"avgChangeRate":0.102416},{"month":3,"riseRate":0.464286,"avgChangeRate":-0.017701},{"month":4,"riseRate":0.464286,"avgChangeRate":0.016582},{"month":5,"riseRate":0.5,"avgChangeRate":-0.005778},{"month":6,"riseRate":0.464286,"avgChangeRate":0.042658},{"month":7,"riseRate":0.37931,"avgChangeRate":0.016432},{"month":8,"riseRate":0.413793,"avgChangeRate":0.029},{"month":9,"riseRate":0.344828,"avgChangeRate":-0.026273},{"month":10,"riseRate":0.37931,"avgChangeRate":0.00045},{"month":11,"riseRate":0.517241,"avgChangeRate":0.053783},{"month":12,"riseRate":0.481481,"avgChangeRate":0.040131}],"exchange":"NASDAQ","name":"Avadel Pharmaceuticals plc","nameEN":"Avadel Pharmaceuticals plc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Avadel Pharmaceuticals plc(AVDL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Avadel Pharmaceuticals plc(AVDL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Avadel Pharmaceuticals plc,AVDL,Avadel Pharmaceuticals plc股票,Avadel Pharmaceuticals plc股票老虎,Avadel Pharmaceuticals plc股票老虎国际,Avadel Pharmaceuticals plc行情,Avadel Pharmaceuticals plc股票行情,Avadel Pharmaceuticals plc股价,Avadel Pharmaceuticals plc股市,Avadel Pharmaceuticals plc股票价格,Avadel Pharmaceuticals plc股票交易,Avadel Pharmaceuticals plc股票购买,Avadel Pharmaceuticals plc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Avadel Pharmaceuticals plc(AVDL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Avadel Pharmaceuticals plc(AVDL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}